CS logo
small CS logo
Central Texas Neurology Consultants

Round Rock, Texas, United States
Doctor in Round Rock, Texas
16040 Park Valley Dr, Round Rock, TX 78681

About Central Texas Neurology Consultants


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Central Texas Neurology Consultants


During the past decade, Central Texas Neurology Consultants conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 11 clinical trials were completed, i.e. on average, 36.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
2001-11-29
2004-01-15
Completed
569
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
2003-02-01
2013-08-01
Completed
470
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600
A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum
2001-07-01
2011-05-01
Completed
326

Rows per page:

1–71 of 71

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Central Texas Neurology Consultants" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Celgene" with 4 trials sponsored, "Genzyme, a Sanofi Company" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "Opexa Therapeutics, Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Central Texas Neurology Consultants" #1 collaborator was "Bayer" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Prothena Biosciences Limited" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Central Texas Neurology Consultants


According to Clinical.Site data, the most researched conditions in "Central Texas Neurology Consultants" are "Multiple Sclerosis" (14 trials), "Multiple Sclerosis, Relapsing-Remitting" (10 trials), "Cervical Dystonia" (2 trials), "Idiopathic Hypersomnia" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "Central Texas Neurology Consultants" in a lesser frequency.

Clinical Trials Intervention Types at Central Texas Neurology Consultants


Most popular intervention types in "Central Texas Neurology Consultants" are "Drug" (34 trials), "Biological" (11 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Ocrelizumab" (5 trials), "Interferon beta-1a" (4 trials), "Alemtuzumab 12 mg" (2 trials) and "Alemtuzumab 24 mg" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Central Texas Neurology Consultants


The vast majority of trials in "Central Texas Neurology Consultants" are 46 trials for "All" genders.

Clinical Trials Status at Central Texas Neurology Consultants


Currently, there are NaN active trials in "Central Texas Neurology Consultants". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Central Texas Neurology Consultants, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Central Texas Neurology Consultants, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status